DAFNA Capital Management as of June 30, 2026
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 88 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 20.1 | $105M | 563k | 187.28 | |
| Spdr S&p Biotech Etf Etf (XBI) | 5.9 | $31M | 197k | 158.25 | |
| Compass Pathways Sponsored Ads (CMPS) | 5.4 | $29M | 2.0M | 14.15 | |
| Stereotaxis Com New (STXS) | 4.5 | $24M | 14M | 1.72 | |
| Nektar Therapeutics Com New (NKTR) | 4.2 | $22M | 318k | 69.81 | |
| Denali Therapeutics (DNLI) | 3.6 | $19M | 739k | 25.72 | |
| Ideaya Biosciences (IDYA) | 3.5 | $19M | 497k | 37.27 | |
| AtriCure (ATRC) | 3.2 | $17M | 597k | 27.98 | |
| Xenon Pharmaceuticals (XENE) | 2.9 | $15M | 251k | 60.36 | |
| Cytokinetics Com New (CYTK) | 2.8 | $15M | 172k | 85.19 | |
| Arcus Biosciences Incorporated (RCUS) | 2.6 | $14M | 442k | 30.83 | |
| Ascendis Pharma A/s Ord Shs (ASND) | 2.5 | $13M | 49k | 266.72 | |
| Neurocrine Biosciences (NBIX) | 1.9 | $9.7M | 58k | 168.53 | |
| Axogen (AXGN) | 1.8 | $9.7M | 209k | 46.19 | |
| Insulet Corporation (PODD) | 1.8 | $9.4M | 62k | 152.25 | |
| Edgewise Therapeutics (EWTX) | 1.8 | $9.2M | 227k | 40.63 | |
| Bicara Therapeutics (BCAX) | 1.6 | $8.5M | 285k | 29.69 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 1.5 | $8.1M | 43k | 190.19 | |
| Syndax Pharmaceuticals (SNDX) | 1.4 | $7.3M | 335k | 21.86 | |
| Maplight Therapeutics (MPLT) | 1.2 | $6.1M | 171k | 35.84 | |
| Larimar Therapeutics (LRMR) | 1.2 | $6.1M | 2.0M | 3.05 | |
| Century Therapeutics (IPSC) | 1.1 | $5.9M | 2.4M | 2.45 | |
| Dex (DXCM) | 1.1 | $5.8M | 86k | 67.35 | |
| Immunovant (IMVT) | 1.1 | $5.8M | 150k | 38.53 | |
| Inogen (INGN) | 1.0 | $5.5M | 845k | 6.45 | |
| Tandem Diabetes Care (TNDM) | 1.0 | $5.4M | 355k | 15.09 | |
| Alkermes SHS (ALKS) | 1.0 | $5.3M | 101k | 52.40 | |
| Stoke Therapeutics (STOK) | 0.8 | $4.3M | 131k | 32.72 | |
| Allogene Therapeutics (ALLO) | 0.8 | $4.2M | 2.0M | 2.08 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $4.0M | 400k | 10.00 | |
| Lakefront Biotherapeutics Nv Spon Adr | 0.7 | $3.9M | 130k | 29.98 | |
| Orthopediatrics Corp. (KIDS) | 0.7 | $3.6M | 189k | 19.13 | |
| Cybin Com New (HELP) | 0.6 | $3.4M | 514k | 6.61 | |
| Rapport Therapeutics (RAPP) | 0.6 | $3.1M | 75k | 41.67 | |
| Kymera Therapeutics (KYMR) | 0.6 | $3.1M | 27k | 114.67 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 0.5 | $2.8M | 1.5M | 1.86 | |
| Neurogene (NGNE) | 0.5 | $2.8M | 89k | 31.45 | |
| Adlai Nortye Sponsored Ads (ANL) | 0.5 | $2.8M | 240k | 11.50 | |
| Procept Biorobotics Corp (PRCT) | 0.5 | $2.7M | 120k | 22.58 | |
| Aquestive Therapeutics (AQST) | 0.5 | $2.7M | 646k | 4.16 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $2.5M | 69k | 37.21 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $2.5M | 47k | 53.67 | |
| Align Technology (ALGN) | 0.5 | $2.4M | 14k | 168.66 | |
| Viking Therapeutics (VKTX) | 0.4 | $2.3M | 60k | 39.01 | |
| Nervgen Pharma Ord (NGEN) | 0.4 | $2.2M | 1.1M | 2.06 | |
| Biohaven (BHVN) | 0.4 | $2.0M | 138k | 14.88 | |
| Maze Therapeatics (MAZE) | 0.4 | $1.9M | 65k | 29.84 | |
| Alector (ALEC) | 0.3 | $1.8M | 908k | 2.01 | |
| Lexeo Therapeutics (LXEO) | 0.3 | $1.8M | 377k | 4.66 | |
| Profound Medical Corp Com New (PROF) | 0.3 | $1.7M | 260k | 6.65 | |
| Atrium Therapeutics (RNA) | 0.3 | $1.7M | 128k | 13.45 | |
| Annexon (ANNX) | 0.3 | $1.7M | 298k | 5.71 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $1.6M | 438k | 3.75 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $1.6M | 47k | 33.39 | |
| Eupraxia Pharmaceuticals (EPRX) | 0.3 | $1.5M | 226k | 6.61 | |
| Design Therapeutics (DSGN) | 0.3 | $1.5M | 103k | 14.47 | |
| Fate Therapeutics (FATE) | 0.3 | $1.4M | 525k | 2.70 | |
| Mediwound Shs New (MDWD) | 0.3 | $1.4M | 94k | 14.70 | |
| Kura Oncology (KURA) | 0.3 | $1.3M | 121k | 10.97 | |
| Silverback Therapeutics (SPRY) | 0.3 | $1.3M | 164k | 8.01 | |
| Mineralys Therapeutics (MLYS) | 0.2 | $1.2M | 45k | 26.98 | |
| Immatics Nv SHS (IMTX) | 0.2 | $1.2M | 117k | 10.13 | |
| Tela Bio (TELA) | 0.2 | $1.1M | 1.4M | 0.75 | |
| Polypid (PYPD) | 0.2 | $1.1M | 208k | 5.08 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.2 | $1.0M | 108k | 9.38 | |
| Inspire Med Sys (INSP) | 0.2 | $812k | 18k | 44.61 | |
| Adicet Bio Com New (ACET) | 0.2 | $811k | 94k | 8.64 | |
| Seaport Therapeutics Common Stock | 0.1 | $704k | 32k | 21.72 | |
| Mbx Biosciences (MBX) | 0.1 | $652k | 12k | 55.20 | |
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $651k | 7.0k | 93.05 | |
| Artiva Biotherapeutics (ARTV) | 0.1 | $651k | 67k | 9.70 | |
| Pliant Therapeutics (PLRX) | 0.1 | $555k | 487k | 1.14 | |
| Scynexis | 0.1 | $553k | 136k | 4.07 | |
| Editas Medicine (EDIT) | 0.1 | $552k | 171k | 3.24 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $547k | 127k | 4.32 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $546k | 112k | 4.88 | |
| Accuray Incorporated (ARAY) | 0.1 | $433k | 1.7M | 0.26 | |
| Q32 Bio (QTTB) | 0.1 | $419k | 33k | 12.74 | |
| Nuvectis Pharma (NVCT) | 0.1 | $368k | 20k | 18.39 | |
| Compugen Ord (CGEN) | 0.1 | $360k | 168k | 2.14 | |
| Ibio Com New (IBIO) | 0.1 | $298k | 170k | 1.75 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $287k | 179k | 1.60 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $273k | 65k | 4.24 | |
| Tenaya Therapeutics (TNYA) | 0.0 | $222k | 300k | 0.74 | |
| Verrica Pharmaceuticals Com Shs (VRCA) | 0.0 | $145k | 24k | 6.12 | |
| Engene Therapeutics (ENGN) | 0.0 | $129k | 75k | 1.73 | |
| Kardigan Ord | 0.0 | $119k | 5.0k | 23.85 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.0 | $83k | 77k | 1.07 |
